Tag: Hudson Institute
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Featured Article
Unlock global potential with Bank of Sydney’s trade finance solutions
In an increasingly globalised economy, Australian manufacturers face the dual challenge of managing complex international supply chains while seizing opportunities for global expansion. Trade finance, a crucial financial tool, can help businesses mitigate risks, improve cash flow, and facilitate cross-border trade with confidence.
